9% of U.S. grocery shoppers now buy high omega-3 food or beverage products in a typical grocery shopping trip.
Awareness of the health benefits of omega-3 market has reached “critical mass,” according to a new Packaged Facts report. It estimates that global consumer spending on omega-3 food and beverage products, excluding fish; health and beauty care products, including supplements; and pet products will reach $13 billion by the end of this year. Moreover, consumer demand for such products will continue growing “briskly” between 2011-2015.
In terms of awareness, Packaged Facts says that 9% of U.S. grocery shoppers now buy high omega-3 food or beverage products in a typical grocery shopping trip. In addition, the percentage of adults taking fish oil supplements has increased from 8% in 2006 to 17% in 2011.
However, it states: “Hurdles do remain for the omega-3 products market. The medical and regulatory communities have not yet fully arrived at a consensus on the optimal intake of omega-3 fatty acids, or the relative benefits of increased consumption of marine- vs. plant-based omega-3 fatty acids, although scientific research has generally focused on the health benefits of DHA and EPA omega-3 from marine sources such as salmon or algae. Correspondingly, there is confusion among consumers who associate ‘omega-3’ with fish and fish oil rather than flax or other plant-based sources that are used in omega-3 fortification of foods. Nonetheless, favorable European regulatory changes for omega-3 health claims are expected in 2011, and should ultimately further boost the omega-3 product marketing environment globally.”
Recent animal study finds that Lysoveta may help reduce neonatal brain injury
July 17th 2024A recent animal study found that lysophosphatidylcholine (LPC)-bound omega-3 long-chain polyunsaturated fatty acids (LCPUFAs), marketed as Lysoveta by Aker BioMarine, protected against neonatal hypoxic-ischemic (HI) brain injury in mice.
Krill oil supplementation raises Omega-3 Index of Lupus patients in recent study
July 16th 2024The study was conducted at 20 research centers in the United States by Aker BioMarine and the Lupus Clinical Investigators Network with oversight by Lupus Therapeutics, the clinical research affiliate of the Lupus Research Alliance.
Meta-analysis does not find increased risk of bleeding events from omega-3 PUFA consumption
July 8th 2024Researchers reviewed 11 studies and found that there was no difference in the incidence of bleeding events between patients receiving omega-3 PUFAs and those not receiving them. High dose EPA consumption was associated with an elevated but modest risk.
Recent review states that pentadecanoic acid may support cellular stability for better longevity
June 25th 2024According to the paper’s author, Stephanie Venn-Watson, DVM, MPH, deficiency in pentadecanoic acid of ≤0.2% total circulating fatty acids increases the risk of ferroptosis, which a type of cell death cause by the peroxidation of fragile fatty acids in cell membranes that combines with iron thus increasing reactive oxygen species, and disabling mitochondria.